145 related articles for article (PubMed ID: 36057903)
1. Surveillance Patterns for Hepatocellular Carcinoma among Screening-Eligible Patients in the Medicare Population.
Papageorge MV; de Geus SWL; Woods AP; Ng SC; Lee S; McAneny D; Tseng JF; Kenzik KM; Sachs TE
Ann Surg Oncol; 2022 Dec; 29(13):8424-8431. PubMed ID: 36057903
[TBL] [Abstract][Full Text] [Related]
2. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis.
Karim MA; Singal AG; Kum HC; Lee YT; Park S; Rich NE; Noureddin M; Yang JD
Cancer Res Commun; 2023 May; 3(5):874-883. PubMed ID: 37377892
[TBL] [Abstract][Full Text] [Related]
4. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
[TBL] [Abstract][Full Text] [Related]
5. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.
Davila JA; Morgan RO; Richardson PA; Du XL; McGlynn KA; El-Serag HB
Hepatology; 2010 Jul; 52(1):132-41. PubMed ID: 20578139
[TBL] [Abstract][Full Text] [Related]
6. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
7. Healthcare Costs for Medicare Patients With Hepatocellular Carcinoma in the United States.
Karim MA; Ramezani M; Leroux T; Kum HC; Singal AG
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2327-2337.e9. PubMed ID: 36435358
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.
Choi DT; Kum HC; Park S; Ohsfeldt RL; Shen Y; Parikh ND; Singal AG
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):976-987.e4. PubMed ID: 30616961
[TBL] [Abstract][Full Text] [Related]
9. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
10. [Hepatocellular carcinoma surveillance].
Costentin C
Presse Med; 2017 Apr; 46(4):381-385. PubMed ID: 28081946
[TBL] [Abstract][Full Text] [Related]
11. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
Daher D; Seif El Dahan K; Yekkaluri S; Gopal P; Rich NE; Parikh ND; Murphy CC; Singal AG
Am J Gastroenterol; 2024 May; 119(5):875-882. PubMed ID: 37975606
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for hepatocellular carcinoma: how can we do better?
Hassett M; Yopp AC; Singal AG
Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
[TBL] [Abstract][Full Text] [Related]
13. Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients.
Demirtas CO; Gunduz F; Tuney D; Baltacioglu F; Kani HT; Bugdayci O; Alahdab YO; Ozdogan OC
Eur J Gastroenterol Hepatol; 2020 Apr; 32(4):517-523. PubMed ID: 31524775
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Hepatocellular Carcinoma Surveillance in an Urban Population With Liver Cirrhosis.
Nusbaum JD; Smirniotopoulos J; Wright HC; Dash C; Parpia T; Shechtel J; Chang Y; Loffredo C; Shetty K
J Clin Gastroenterol; 2015; 49(10):e91-5. PubMed ID: 25751372
[TBL] [Abstract][Full Text] [Related]
15. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
[TBL] [Abstract][Full Text] [Related]
16. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohort.
Chen VL; Singal AG; Tapper EB; Parikh ND
Liver Int; 2020 Apr; 40(4):947-955. PubMed ID: 31943689
[TBL] [Abstract][Full Text] [Related]
18. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
Trinchet JC; Nahon P; Ganne-Carrie N
Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for hepatocellular carcinoma in a Medicaid cirrhotic population.
Palmer LB; Kappelman MD; Sandler RS; Hayashi PH
J Clin Gastroenterol; 2013 Sep; 47(8):713-8. PubMed ID: 23442840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]